Exane Derivatives’s Douglas Emmett DEI Stock Holding History

Exane Derivatives’s Portfolio DEI Stock Details DEI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25	Closed	-$766	–	759
2020 Q2	$766	Hold	25	–	–	﹤0.01%	573
2020 Q1	$763	Hold	25	–	–	﹤0.01%	560
2019 Q4	$1.04K	Sell	25 -5,191	-100%	-$225K	﹤0.01%	543
2019 Q3	$223K	Buy	5,216 +350	+7%	+$14.5K	0.04%	234
2019 Q2	$194K	Buy	+4,866	New	+$199K	0.03%	278
2018 Q3	–	Sell	-7,452	Closed	-$299K	–	703
2018 Q2	$299K	Sell	7,452 -388	-5%	-$14.7K	0.05%	214
2018 Q1	$288K	Buy	+7,840	New	+$294K	0.06%	212

Other funds holding DEI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exane Derivatives's DEI Position: Q3 2020 in Review

Exane Derivatives sold out of Douglas Emmett (DEI) in Q3 2020, closing a stake of 25 shares — an estimated $766 sold.

Exane Derivatives first reported a position in DEI in Q1 2018 and held it in 7 quarters. The position peaked at $299K in Q2 2018. 247 funds tracked by Wall St. Rank hold DEI as of Q3 2020.

Exane Derivatives reported no remaining Douglas Emmett position as of Q3 2020 after selling out during the quarter.
Exane Derivatives sold 25 Douglas Emmett shares in Q3 2020, an estimated $766.
Exane Derivatives first reported a position in Douglas Emmett in Q1 2018 and held it in 7 quarters.
Exane Derivatives's Douglas Emmett position peaked at $299K in Q2 2018.
247 funds tracked by Wall St. Rank held Douglas Emmett as of Q3 2020.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.